Psilos Group has been a successful healthcare private equity firm since its founding in 1998 and currently has over $500 million under management. We focus our investments across the healthcare services, healthcare information technology, and medical device & instrumentation sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Our portfolio companies are sustainable and high value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives.  Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

Psilos Commits $13 Million Follow-on Investment in HealthEdge (pdf) 

Rave Reviews for InSound's Lyric (pdf) 

IntelliDOT Secures Exclusive Contract with Premier Purchasing Partners LP for its CAREt™ System (pdf) 

Health Evolution Partners Launches Innovation Network (pdf) 

GE Healthcare Acquires VersaMed (pdf) 

Stanford Study Finds Cancer Detected Earlier, Faster with New Medical Imaging (pdf) 

IntelliDOT to Install CAREt™ at Fremont-Rideout Healthcare Group Facilities (pdf) 

AngioScore Obtains Japanese Approval for AngioSculpt Scoring Balloon Catheter (pdf) 

Psilos III Invests in Mauna Kea (pdf) 

OPKO Health Appoints Dr. Naveed Shams as Chief Medical Officer (pdf) 

 

 

©2006 Psilos Group All rights reserved. About Psilos | Investment Criteria | Portfolio Companies | News | Contact Us | Legal